LSA
SUPN icon

Leonteq Securities AG’s Supernus Pharmaceuticals SUPN Stock Holding History

Leonteq Securities AG’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-520
Closed -$15.6K – 1289
2023
Q2 		$15.6K Hold
520
– – ﹤0.01% 985
2023
Q1 		$18.8K Hold
520
– – ﹤0.01% 930
2022
Q4 		$18.5K Hold
520
– – ﹤0.01% 975
2022
Q3 		$17.6K Hold
520
– – ﹤0.01% 974
2022
Q2 		$15K Hold
520
– – ﹤0.01% 1023
2022
Q1 		$16.8K Hold
520
– – ﹤0.01% 1028
2021
Q4 		$15.2K Buy
+520
New +$15.8K ﹤0.01% 1110

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Leonteq Securities AG's SUPN Position: Q3 2023 in Review

Leonteq Securities AG sold out of Supernus Pharmaceuticals (SUPN) in Q3 2023, closing a stake of 520 shares — an estimated $15.6K sold.

Leonteq Securities AG first reported a position in SUPN in Q4 2021 and held it in 7 quarters. The position peaked at $18.8K in Q1 2023. 238 funds tracked by Wall St. Rank hold SUPN as of Q3 2023.

  • Leonteq Securities AG reported no remaining Supernus Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 520 Supernus Pharmaceuticals shares in Q3 2023, an estimated $15.6K.
  • Leonteq Securities AG first reported a position in Supernus Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Leonteq Securities AG's Supernus Pharmaceuticals position peaked at $18.8K in Q1 2023.
  • 238 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2023.

Based on Leonteq Securities AG's 13F filing for Q3 2023, filed 11 Mar 2026.